Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tamar Robotics was an Israeli medtech company developing a miniature endoscopic robotic surgical system for minimally invasive procedures in small cavities, initially focused on neurosurgery. Its core product, the Tamar System, was designed to enable highly accurate and safe robotic manipulation in confined anatomical spaces where conventional surgical robots are difficult to use. The company positioned the platform for brain procedures including pituitary, intraventricular, skull-base tumor, glioma, and intracerebral hemorrhage interventions, with broader stated applicability to spine, head, and urology surgery. Tamar Robotics was founded in 2018 by Prof. Moshe Shoham and Hadas Ziso, with technology rooted in research at the Technion. Available business databases indicate the company had seed funding and later appears to have ceased operations in late 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tamar Robotics.